0,904  0,003  Aldehyde oxidase inhibitor
0,885  0,004  Caspase 9 stimulant
0,866  0,002  Antimutagenic
0,854  0,003  UGT1A6 substrate
0,830  0,003  CTGF expression inhibitor
0,821  0,004  UGT1A9 substrate
0,801  0,003  Genotoxic
0,792  0,018  Apoptosis agonist
0,780  0,009  TNF expression inhibitor
0,761  0,013  Antineoplastic (breast cancer)
0,755  0,010  Antineoplastic (colorectal cancer)
0,757  0,012  Antineoplastic (lung cancer)
0,749  0,010  Antineoplastic (colon cancer)
0,740  0,002  Cystathionine beta-synthase inhibitor
0,742  0,005  NOS2 expression inhibitor
0,737  0,003  UGT1A3 substrate
0,734  0,005  Caspase 3 stimulant
0,732  0,010  Antileukemic
0,716  0,006  Antineoplastic (cervical cancer)
0,701  0,010  Prostate cancer treatment
0,692  0,005  CYP1A2 inhibitor
0,689  0,005  UGT1A1 substrate
0,687  0,008  12-Lipoxygenase inhibitor
0,659  0,007  Antineoplastic (non-small cell lung cancer)
0,665  0,016  15-Lipoxygenase inhibitor
0,651  0,003  UGT2B15 substrate
0,656  0,013  Chemoprotective
0,646  0,005  Ulceration
0,641  0,007  Free radical scavenger
0,636  0,005  GABA C receptor rho-3 antagonist
0,638  0,007  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,630  0,007  Antineoplastic (glioma)
0,628  0,010  Antineoplastic (melanoma)
0,611  0,004  Peroxidase inhibitor
0,621  0,014  Antineoplastic (ovarian cancer)
0,615  0,010  Antioxidant
0,607  0,005  Antineoplastic (osteosarcoma)
0,591  0,006  Antineoplastic (glioblastoma multiforme)
0,594  0,011  AR expression inhibitor
0,588  0,008  Amyloid beta aggregation inhibitor
0,587  0,011  Lipoxygenase inhibitor
0,589  0,013  Cytostatic
0,589  0,016  Sensitization
0,573  0,005  Tubulin antagonist
0,570  0,005  Topoisomerase II inhibitor
0,579  0,015  Mutagenic
0,591  0,032  Transcription factor NF kappa B inhibitor
0,562  0,005  Antineoplastic (small cell lung cancer)
0,565  0,009  Hypoxia-inducible factor 1 alpha inhibitor
0,558  0,009  UDP-glucuronosyltransferase substrate
0,549  0,010  DNA damaging
0,554  0,018  CYP1A2 substrate
0,539  0,013  Antiprotozoal (Leishmania)
0,530  0,006  Antiseptic
0,539  0,017  Chemopreventive
0,534  0,015  Antineoplastic (brain cancer)
0,534  0,018  Antineoplastic (pancreatic cancer)
0,529  0,018  Cardioprotectant
0,514  0,004  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,535  0,029  Antiprotozoal
0,527  0,021  Histamine release inhibitor
0,514  0,008  Antineoplastic (carcinoma)
0,524  0,025  5 Hydroxytryptamine release inhibitor
0,507  0,009  UGT1A4 substrate
0,502  0,005  Breast cancer-resistant protein inhibitor
0,516  0,022  Aryl hydrocarbon receptor agonist
0,498  0,006  Antineoplastic (bladder cancer)
0,512  0,023  Calcium channel L-type activator
0,491  0,004  NADPH oxidase inhibitor
0,492  0,007  Antineoplastic (squamous cell carcinoma)
0,507  0,022  CYP2C19 inhibitor
0,485  0,007  Dual specificity phosphatase inhibitor
0,485  0,009  Antineoplastic (sarcoma)
0,485  0,012  RNA-directed DNA polymerase inhibitor
0,485  0,013  UGT2B4 substrate
0,485  0,014  Superoxide dismutase inhibitor
0,485  0,016  Cardiodepressant
0,475  0,012  Antihypoxic
0,470  0,009  Monophenol monooxygenase inhibitor
0,466  0,007  Amylase inhibitor
0,469  0,012  Pyruvate kinase inhibitor
0,476  0,023  NOS3 expression inhibitor
0,455  0,003  NAD(P)H dehydrogenase (quinone) inhibitor
0,455  0,009  Skin whitener
0,519  0,075  Alpha-glucosidase inhibitor
0,448  0,004  Topoisomerase II alpha inhibitor
0,466  0,022  Cardiovascular analeptic
0,451  0,011  Transcription factor STAT3 inhibitor
0,470  0,031  Antiprotozoal (Plasmodium)
0,448  0,012  Transcription factor STAT inhibitor
0,480  0,045  GST A substrate
0,438  0,003  Coagulant
0,444  0,012  Calcium channel activator
0,453  0,022  Proliferative diseases treatment
0,440  0,012  P-glycoprotein inhibitor
0,462  0,034  CYP2C9 inhibitor
0,454  0,027  Carcinogenic
0,486  0,060  Antineoplastic (solid tumors)
0,467  0,043  CYP2C9 substrate
0,447  0,031  Cytotoxic
0,459  0,046  Antipruritic, allergic
0,431  0,018  Antihypertriglyceridemic
0,464  0,052  Antibacterial
0,446  0,037  5 Hydroxytryptamine release stimulant
0,428  0,020  Radiosensitizer
0,422  0,019  Antineoplastic (renal cancer)
0,411  0,010  GST M1-1 substrate
0,409  0,011  Melanin inhibitor
0,398  0,003  GABA C receptor rho-2 antagonist
0,401  0,009  Pneumotoxic
0,409  0,017  Antineoplastic (lymphocytic leukemia)
0,410  0,019  Antineoplastic enhancer
0,391  0,003  Creatine kinase inhibitor
0,411  0,026  Antipyretic
0,419  0,035  Radioprotector
0,404  0,022  Antimitotic
0,383  0,005  Hexokinase inhibitor
0,388  0,010  DNA methyltransferase I inhibitor
0,403  0,028  Antiamyloidogenic
0,380  0,005  Interleukin 4 antagonist
0,379  0,005  Antihemorrhagic
0,406  0,033  Vasodilator, coronary
0,369  0,003  CDC25B inhibitor
0,390  0,025  Antineoplastic (liver cancer)
0,397  0,032  Antineoplastic (multiple myeloma)
0,370  0,006  5-Lipoxygenase inhibitor
0,366  0,003  VEGF expression inhibitor
0,370  0,010  Antineoplastic (gastric cancer)
0,368  0,007  Glutathione S-transferase substrate
0,364  0,004  Electron transport complex I inhibitor
0,373  0,013  Carcinogenic, group 3
0,403  0,044  FMO1 substrate
0,379  0,020  Cyclic AMP phosphodiesterase inhibitor
0,420  0,061  Prostaglandin dehydrogenase inhibitor
0,360  0,003  CDC25A inhibitor
0,369  0,014  DNA methylase inhibitor
0,382  0,028  Nitric oxide antagonist
0,369  0,021  5 Hydroxytryptamine uptake stimulant
0,375  0,031  Antineoplastic (lymphoma)
0,346  0,004  Beta tubulin antagonist
0,373  0,032  Tumour necrosis factor alpha release inhibitor
0,344  0,007  SULT1A3 substrate
0,343  0,005  Xanthine oxidase inhibitor
0,342  0,005  T cell inhibitor
0,348  0,012  Protein-tyrosine phosphatase inhibitor
0,344  0,009  Heat shock protein 90 alpha antagonist
0,377  0,045  Apoptosis antagonist
0,393  0,064  CYP3A4 substrate
0,338  0,009  Sulfotransferase substrate
0,361  0,037  Antiprotozoal (Trypanosoma)
0,345  0,021  Dual specificity phosphatase 3 inhibitor
0,341  0,018  Tyrosine 3 hydroxylase inhibitor
0,328  0,007  Heat shock protein 90 antagonist
0,366  0,047  CYP2C19 substrate
0,368  0,050  Antihypercholesterolemic
0,435  0,118  Antiinflammatory
0,336  0,020  Antihypotensive
0,325  0,009  Topoisomerase I inhibitor
0,322  0,007  Nitric-oxide synthase stimulant
0,327  0,013  MAO A inhibitor
0,362  0,049  Teratogen
0,327  0,015  Lipid peroxidase inhibitor
0,366  0,054  ICAM1 expression inhibitor
0,315  0,004  SULT1A1 substrate
0,365  0,057  Streptokinase A inhibitor
0,326  0,021  UGT2B7 substrate
0,377  0,073  Immunosuppressant
0,312  0,009  Succinate dehydrogenase inhibitor
0,336  0,033  DNA synthesis inhibitor
0,314  0,012  Alkylator
0,315  0,015  Tumour necrosis factor antagonist
0,314  0,015  GST P1-1 substrate
0,314  0,015  Protein kinase stimulant
0,332  0,036  Antiparasitic
0,317  0,021  VCAM1 expression inhibitor
0,299  0,004  Alpha tubulin antagonist
0,335  0,041  Hypoglycemic
0,352  0,060  Antifungal
0,306  0,016  Neurotrophic factor enhancer
0,312  0,026  Hepatoprotectant
0,296  0,010  Antiprotozoal (Coccidial)
0,297  0,012  Aldehyde dehydrogenase inhibitor
0,310  0,026  Non-steroidal antiinflammatory agent
0,292  0,009  LDLR expression enhancer
0,287  0,005  HIV-1 integrase (3'-Processing) inhibitor
0,293  0,014  Acetylcholinesterase inhibitor
0,289  0,010  Carcinogenic, group 2B
0,319  0,042  Vasodilator
0,283  0,007  UGT2B10 substrate
0,277  0,005  HIV-1 integrase (Strand Transfer) inhibitor
0,293  0,021  MAO inhibitor
0,338  0,069  Cholesterol antagonist
0,280  0,013  Chelator
0,289  0,021  CYP2B6 inhibitor
0,320  0,055  Embryotoxic
0,296  0,032  Antihelmintic
0,276  0,016  M18 aspartyl aminopeptidase inhibitor
0,282  0,023  Interferon gamma antagonist
0,270  0,012  Antineoplastic antibiotic
0,265  0,007  Toll-Like receptor 2 antagonist
0,315  0,058  Antineoplastic (endocrine cancer)
0,264  0,009  Mannose-6-phosphate isomerase inhibitor
0,262  0,008  Carbonic anhydrase III inhibitor
0,271  0,019  Antidote
0,255  0,005  Antihelmintic (Trematoda)
0,253  0,005  Multidrug resistance-associated protein 1 inhibitor
0,318  0,072  CYP2D6 substrate
0,249  0,005  Keratolytic
0,261  0,018  Alkaline phosphatase inhibitor
0,312  0,070  Respiratory analeptic
0,293  0,052  Interleukin agonist
0,308  0,067  Spasmolytic
0,278  0,040  Abortion inducer
0,310  0,073  Antimycobacterial
0,241  0,005  Antineoplastic (uterine cancer)
0,311  0,076  Hepatic disorders treatment
0,247  0,012  Catenin beta inhibitor
0,241  0,007  Photosensitizer
0,251  0,017  Antifungal enhancer
0,250  0,018  Carcinogenic, group 1
0,257  0,025  NOS3 expression enhancer
0,248  0,016  DNA intercalator
0,262  0,032  Mcl-1 antagonist
0,285  0,055  Angiogenesis stimulant
0,247  0,021  Antineoplastic (bone cancer)
0,237  0,011  Antirickettsial
0,229  0,005  GABA C receptor rho-1 antagonist
0,281  0,057  Vascular (periferal) disease treatment
0,250  0,031  Antihelmintic (Nematodes)
0,298  0,081  Sodium/bile acid cotransporter inhibitor
0,250  0,034  Insulin sensitizer
0,305  0,091  Thyroid hormone antagonist
0,238  0,024  UGT2B9 substrate
0,225  0,013  UGT2B1 substrate
0,223  0,012  Cyclooxygenase 3 inhibitor
0,219  0,011  Histidine decarboxylase inhibitor
0,214  0,007  Thioredoxin inhibitor
0,347  0,139  DNA directed DNA polymerase inhibitor
0,267  0,060  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,219  0,013  CF transmembrane conductance regulator agonist
0,209  0,004  Antifungal (Pneumocystis)
0,295  0,091  Thyroid hormone beta antagonist
0,292  0,094  Antithrombotic
0,221  0,023  Protein-tyrosine phosphatase 1B inhibitor
0,201  0,004  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,206  0,012  GABA C receptor antagonist
0,245  0,051  Platelet adhesion inhibitor
0,197  0,005  Thioredoxin reductase inhibitor
0,200  0,011  AMP-activated protein kinase stimulant
0,269  0,080  Antituberculosic
0,208  0,020  Antibacterial (Helicobacter pylori)
0,214  0,026  Aldose reductase substrate
0,333  0,147  DNA polymerase beta inhibitor
0,199  0,014  Telomerase inhibitor
0,198  0,013  Carbonic anhydrase VI inhibitor
0,211  0,029  ATPase inhibitor
0,202  0,020  Antiprotozoal (Trichomonas)
0,191  0,008  DOPA decarboxylase inhibitor
0,217  0,035  Antiviral (Ebola)
0,195  0,013  Beta glucuronidase inhibitor
0,210  0,029  Phobic disorders treatment
0,223  0,044  Amyloid beta precursor protein antagonist
0,183  0,004  Heat shock protein 90 beta antagonist
0,222  0,043  Histone acetyltransferase inhibitor
0,225  0,046  Antipruritic, non-allergic
0,251  0,074  Myocardial infarction treatment
0,183  0,005  Xanthine dehydrogenase inhibitor
0,215  0,040  Cholinergic
0,187  0,012  Carcinogenic, group 2A
0,186  0,011  DNA repair enzyme inhibitor
0,262  0,091  FMO3 substrate
0,190  0,020  Carbonic anhydrase XV inhibitor
0,201  0,032  Hemostatic
0,201  0,033  Arachidonic acid antagonist
0,185  0,017  Mucolytic
0,184  0,016  Carbonic anhydrase XIII inhibitor
0,172  0,008  UGT2B11 substrate
0,187  0,023  Expectorant
0,180  0,016  HIV-1 integrase (Overall Integration) inhibitor
0,174  0,010  Ca2+-transporting ATPase inhibitor
0,242  0,079  Antidiabetic symptomatic
0,178  0,016  Estrogen antagonist
0,190  0,029  Gout treatment
0,170  0,009  Aldose reductase inhibitor
0,261  0,099  Analeptic
0,179  0,019  Gastritis treatment
0,221  0,062  Antiviral (Influenza)
0,171  0,012  Estrogen receptor beta antagonist
0,236  0,078  Dyrk kinase inhibitor
0,241  0,084  5 Hydroxytryptamine 1E antagonist
0,183  0,028  MAO B inhibitor
0,193  0,039  Neurotensin receptor agonist
0,164  0,012  SULT1E1 substrate
0,176  0,027  Microtubule formation inhibitor
0,264  0,117  Vasodilator, peripheral
0,151  0,005  D-Ala-D-Ala ligase inhibitor
0,169  0,022  Potassium channel (Ca-activated) activator
0,187  0,041  Cytokine production inhibitor
0,167  0,021  Antihelmintic (Fasciola)
0,169  0,024  Vanilloid 1 agonist
0,197  0,053  Antianorexic
0,159  0,015  Antiprotozoal (Toxoplasma)
0,149  0,006  Estradiol 17 beta-dehydrogenase inhibitor
0,183  0,042  Cyclooxygenase 1 inhibitor
0,172  0,031  Antiprotozoal (Amoeba)
0,175  0,034  Cholesterol synthesis inhibitor
0,191  0,051  Acaricide
0,154  0,015  Antiviral (Trachoma)
0,242  0,104  Insulysin inhibitor
0,160  0,021  Chronic obstructive bronchitis treatment
0,158  0,020  Antispirochetal
0,214  0,077  Interleukin antagonist
0,165  0,029  Butyrylcholinesterase inhibitor
0,143  0,007  Granulocyte macrophage colony stimulating factor agonist
0,163  0,027  Choleretic
0,168  0,033  Protein kinase (CK2) alpha inhibitor
0,147  0,014  Glutamate decarboxylase inhibitor
0,139  0,009  Antidote, heavy metal
0,140  0,010  HIV-1 integrase inhibitor
0,159  0,029  Heat shock protein 70 antagonist
0,184  0,056  Phospholipase C inhibitor
0,212  0,085  Peptidyltransferase inhibitor
0,133  0,006  Topoisomerase II beta inhibitor
0,172  0,045  Interleukin 1 antagonist
0,229  0,106  Gastrin inhibitor
0,248  0,125  Angiogenesis inhibitor
0,135  0,014  Estrogen receptor alpha antagonist
0,226  0,107  Immunostimulant
0,299  0,180  MAP kinase 1 inhibitor
0,175  0,057  Uterine stimulant
0,125  0,007  Antimycoplasmal
0,133  0,015  Myeloperoxidase inhibitor
0,123  0,006  Fatty acid synthase inhibitor
0,145  0,028  Dementia treatment
0,162  0,045  Adenylate cyclase stimulant
0,144  0,028  Transcription factor STAT6 inhibitor
0,133  0,017  Cyclin B3 inhibitor
0,210  0,095  Antiviral (West Nile virus)
0,118  0,003  Nucleoside transporters inhibitor
0,240  0,125  CYP3A4 inhibitor
0,153  0,038  Interleukin 1b antagonist
0,175  0,062  Eye irritation, high
0,127  0,013  Alcohol oxidase inhibitor
0,154  0,042  Antitussive
0,132  0,021  Macrophage migration inhibitory factor inhibitor
0,144  0,033  Antiviral (Influenza B)
0,138  0,028  Vascular dementia treatment
0,139  0,030  Sphingomyelinase inhibitor
0,126  0,017  Aromatase inhibitor
0,135  0,029  Arylamine N-Acetyltransferase substrate
0,135  0,029  Uric acid excretion stimulant
0,132  0,027  Alcohol dehydrogenase inhibitor
0,187  0,083  I kappa B kinase epsilon inhibitor
0,109  0,007  Potassium channel Kv1.3 blocker
0,153  0,053  Alpha-N-acetylglucosaminidase inhibitor
0,161  0,061  Cyclooxygenase inhibitor
0,116  0,019  Histone deacetylase SIRT1 stimulant
0,116  0,019  Histone deacetylase stimulant
0,112  0,016  Narcotic antagonist
0,104  0,009  Glutamate (mGluR7) antagonist
0,132  0,036  UDP-glucose 4-epimerase inhibitor
0,170  0,075  3C-like protease (Human coronavirus) inhibitor
0,303  0,209  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,108  0,014  Maillard reaction inhibitor
0,185  0,092  MAP kinase kinase 2 inhibitor
0,119  0,029  Antidote, mercury
0,124  0,036  Anabolic
0,106  0,018  Estrogen-related receptor beta agonist
0,127  0,039  Urease inhibitor
0,124  0,036  Prolactin inhibitor
0,165  0,077  Aldehyde oxidase substrate
0,114  0,027  Glutamate release inhibitor
0,141  0,054  DNA polymerase I inhibitor
0,098  0,011  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,100  0,013  Aryl hydrocarbon receptor antagonist
0,129  0,043  Protein kinase (CK2) inhibitor
0,114  0,028  Interleukin 5 antagonist
0,101  0,015  GABA B receptor agonist
0,108  0,022  Leukotriene synthesis inhibitor
0,146  0,060  Pregnane X receptor agonist
0,116  0,031  NADH dehydrogenase inhibitor
0,093  0,009  Transcription factor RelA inhibitor
0,104  0,022  Potassium channel large-conductance Ca-activated activator
0,160  0,079  Sigma receptor agonist
0,153  0,071  Phospholipase A2 inhibitor
0,260  0,179  Transcription factor inhibitor
0,123  0,045  Mediator release inhibitor
0,131  0,054  Sphingosine 1-phosphate receptor 4 antagonist
0,124  0,048  NAT2 substrate
0,170  0,094  Anesthetic general
0,100  0,024  SULT1A2 substrate
0,107  0,031  ATPase (Vacuolar H+) inhibitor
0,094  0,019  MAP kinase kinase 7 inhibitor
0,084  0,009  DNA helicase inhibitor
0,112  0,037  Interleukin 12 antagonist
0,087  0,013  Cyclin D1 inhibitor
0,118  0,045  Antiviral (SARS coronavirus)
0,118  0,045  Antiviral (Coronavirus)
0,136  0,065  Cyclooxygenase 2 inhibitor
0,213  0,142  Bone diseases treatment
0,075  0,005  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,090  0,020  Estrogen agonist
0,115  0,047  GST T1-1 substrate
0,112  0,044  Antifungal (Aspergillus)
0,118  0,051  Acetylcholine release stimulant
0,131  0,065  Antihyperlipoproteinemic
0,102  0,036  Phosphodiesterase 4D inhibitor
0,126  0,060  Contraceptive female
0,136  0,071  Bone formation stimulant
0,144  0,079  Antiviral (Influenza A)
0,105  0,041  Aminoacyl-tRNA synthetase inhibitor
0,086  0,023  Protease 3C (Human rhinovirus) inhibitor
0,090  0,026  Leukotriene antagonist
0,071  0,008  Inosine monophosphate dehydrogenase inhibitor
0,076  0,013  Dihydroorotate oxidase inhibitor
0,121  0,059  Skin irritative effect
0,078  0,017  Calcium channel P-type blocker
0,075  0,014  CD45 antagonist
0,096  0,036  Antibiotic
0,082  0,022  SULT2A1 substrate
0,134  0,074  Toll-Like receptor 9 antagonist
0,250  0,190  MAP kinase kinase 6 inhibitor
0,068  0,009  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,071  0,013  Pregnane X receptor antagonist
0,101  0,043  Ornithine decarboxylase inhibitor
0,073  0,014  Ryanodine receptor antagonist
0,093  0,036  Cathepsin G inhibitor
0,111  0,056  GABA C receptor agonist
0,118  0,063  Caspase 3 inhibitor
0,086  0,032  Glycine receptor agonist
0,101  0,047  Triose-phosphate isomerase inhibitor
0,058  0,005  ATP citrate lysase inhibitor
0,089  0,036  GABA aminotransferase inhibitor
0,092  0,040  Porphobilinogen synthase inhibitor
0,099  0,047  Androgen antagonist
0,101  0,049  Protein kinase C zeta inhibitor
0,100  0,050  Antiviral (Rhinovirus)
0,126  0,076  Toll-Like receptor antagonist
0,070  0,021  Postcoital contraceptive
0,102  0,055  Antineoplastic, alkylator
0,097  0,050  Calcium antagonist
0,105  0,058  Bronchodilator
0,074  0,029  Purinergic P2X1 antagonist
0,071  0,026  Postmenopausal disorders treatment
0,065  0,020  Glucose-6-phosphate translocase inhibitor
0,109  0,064  Excitatory amino acid transporter EAAC1 inhibitor
0,114  0,070  Proteasome inhibitor
0,134  0,090  Thiol protease inhibitor
0,080  0,037  Carbonic anhydrase VA inhibitor
0,154  0,112  Psychostimulant
0,077  0,036  Anticholelithogenic
0,050  0,009  Vanilloid 3 antagonist
0,055  0,014  Dopamine D5 agonist
0,086  0,045  Na+ K+ transporting ATPase inhibitor
0,132  0,091  Antianemic
0,073  0,034  Beta adrenoreceptor antagonist
0,059  0,020  Carbonic anhydrase VII inhibitor
0,054  0,014  DNA gyrase subunit A inhibitor
0,206  0,167  Thioredoxin glutathione reductase inhibitor
0,181  0,142  Antiosteoporotic
0,086  0,048  Caspase 7 inhibitor
0,062  0,025  Leukotriene B4 antagonist
0,073  0,037  Dopamine D1 antagonist
0,050  0,015  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,093  0,058  Paget's disease treatment
0,074  0,039  Carbonic anhydrase V inhibitor
0,058  0,024  CXC chemokine 1 receptor antagonist
0,037  0,003  Antibiotic Anthracycline-like
0,047  0,013  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,130  0,096  Insulin secretagoues
0,078  0,045  Antitreponemal
0,091  0,058  Actinic keratosis treatment
0,130  0,097  Antiviral (Herpes)
0,051  0,019  Estrogen receptor beta agonist
0,054  0,024  Cholesterol esterase inhibitor
0,085  0,054  Inducible nitric-oxide synthase inhibitor
0,118  0,087  Papain-like protease (SARS coronavirus) inhibitor
0,125  0,095  Cytidine deaminase inhibitor
0,056  0,027  Anesthetic inhalation
0,080  0,051  Antidote, organophosphates
0,123  0,095  Cell wall synthesis inhibitor
0,088  0,059  Tocolytic
0,067  0,039  Beta 3 adrenoreceptor antagonist
0,072  0,044  Purinergic P2X2 antagonist
0,046  0,019  Estrogen receptor alpha agonist
0,049  0,022  DNA-dependent protein kinase inhibitor
0,075  0,049  Glutamate dehydrogenase inhibitor
0,083  0,057  Glutathione S-transferase inhibitor
0,135  0,109  Movement disorders treatment
0,033  0,007  Inosine monophosphate dehydrogenase 2 inhibitor
0,084  0,059  Vanilloid agonist
0,036  0,011  Protein 30S ribosomal subunit inhibitor
0,092  0,067  MAP kinase kinase 1 inhibitor
0,040  0,016  Sodium-dependent vitamin C transporter 2 inhibitor
0,120  0,096  Psychosexual dysfunction treatment
0,140  0,115  Hearing loss treatment
0,055  0,031  Vanilloid 2 antagonist
0,026  0,003  Antibiotic Tetracycline-like
0,058  0,034  5 Hydroxytryptamine 7 agonist
0,039  0,015  Catechol O-methyltransferase inhibitor
0,062  0,039  Heme oxygenase stimulant
0,074  0,051  NAT1 substrate
0,191  0,168  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,050  0,027  Adenylate cyclase 1 inhibitor
0,104  0,081  TRPA1 agonist
0,108  0,085  Growth stimulant
0,123  0,101  CC chemokine 6 receptor antagonist
0,057  0,035  Leukotriene C antagonist
0,057  0,037  Human rhinovirus A protease inhibitor
0,135  0,116  Interleukin 6 antagonist
0,078  0,059  Xanthine oxidase substrate
0,095  0,076  Adenylate kinase inhibitor
0,093  0,075  Glutamate (mGluR7) agonist
0,095  0,078  Toll-Like receptor 4 antagonist
0,050  0,033  Carbonic anhydrase XIV inhibitor
0,072  0,057  CYP2A6 inhibitor
0,034  0,019  Estrogen-related receptor beta antagonist
0,103  0,089  Antiprotozoal (Babesia)
0,043  0,029  Leukocyte elastase inhibitor
0,066  0,051  Phosphofructokinase-1 inhibitor
0,081  0,067  3C-Like protease (SARS coronavirus) inhibitor
0,119  0,106  Farnesoid X receptor antagonist
0,029  0,016  Hedgehog signaling activator
0,062  0,050  Neuraminidase (influenza) inhibitor
0,047  0,035  Glucose-6-phosphate isomerase inhibitor
0,033  0,023  Protein kinase (CK2) beta inhibitor
0,042  0,031  GABA B receptor antagonist
0,084  0,074  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,023  0,014  Leukotriene B4 receptor 2 antagonist
0,049  0,040  Aconitate hydratase inhibitor
0,062  0,055  Phenylalanine 4-hydroxylase inhibitor
0,063  0,056  Glutamate (mGluR6) antagonist
0,063  0,056  Endocannabinoid uptake inhibitor
0,033  0,026  Phosphoglycerate kinase inhibitor
0,086  0,079  Interleukin 1 beta converting enzyme inhibitor
0,046  0,042  Dihydroorotate dehydrogenase inhibitor
0,046  0,042  Lysophosphatidic acid 3 receptor antagonist
0,069  0,065  Phosphodiesterase VI inhibitor
0,024  0,022  Sodium/glucose cotransporter 2 inhibitor
0,035  0,033  Glutamate (mGluR8) agonist
0,176  0,175  Flavin-containing monooxygenase substrate
0,038  0,037  Guanylate cyclase inhibitor
0,072  0,071  Glycine receptor antagonist

